In human studies, a polymorphic version of ApoA-IV has been shown to highly efficiently activate lecithin cholesterol acyl transferase, and a polymorphic version of ApoA-IV may be linked to high AD risk [118]. The gene discussed is APOA4; the disease is Alzheimer disease.